Daewoong Pharmaceutical and HanAll Biopharma Invest in Turn Biotechnologies to Expand Growth Initiative
Daewoong Pharmaceutical and HanAll Biopharma invest in the broad potential of Turn Biotechnologies Turn has developed a novel cell rejuvenating platform with significant potential for application in an array of age-related diseases Daewoong Pharmaceutical and HanAll Biopharma today announced expansion of…